GGrantIndex
← Leaderboards

Daniel T Eitzman

Veterans Health Administration

$7,505,777
Attributed
$7,505,777
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$7,505,777 · 5
VA$0 · 3

By mechanism

R01$4,857,859 · 2
P01$1,412,144 · 1
T32$1,006,814 · 1
K08$228,960 · 1
I01$0 · 3

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Atherosclerosis

Research focus

AtherosclerosisBlood VesselsInflammationLinkMouse ModelMediator Of Activation ProteinVascular DiseasesMediatingMyocardial InfarctionCardiovascular SystemLeukocytesObesityInflammatoryAtherogenesisIn VivoCardiovascular Risk FactorUnited StatesLeadPreventAdhesivesStrokeBone MarrowTherapeutic TargetEvent

Grant awards (34)

Traumatic Brain Injury and Vascular Disease$0
I01 · FY2024 · VA · contact PI
Traumatic Brain Injury and Vascular Disease$0
I01 · FY2023 · VA · contact PI
Traumatic Brain Injury and Vascular Disease$0
I01 · FY2022 · VA · contact PI
Traumatic Brain Injury and Vascular Disease$0
I01 · FY2021 · VA · contact PI
Leukocyte Regulation of Vascular Function$0
I01 · FY2019 · VA · contact PI
Leukocyte Regulation of Vascular Function$0
I01 · FY2018 · VA · contact PI
Leukocyte Regulation of Vascular Function$0
I01 · FY2017 · VA · contact PI
NETs in the development of lupus and its cardiovascular complications$401,760
R01 · FY2016 · HL · contact PI
Leukocyte Regulation of Vascular Function$0
I01 · FY2016 · VA · contact PI
NETs in the development of lupus and its cardiovascular complications$395,579
R01 · FY2015 · HL · contact PI
NETs in the development of lupus and its cardiovascular complications$393,580
R01 · FY2014 · HL · contact PI
NETs in the development of lupus and its cardiovascular complications$395,545
R01 · FY2013 · HL · contact PI
Regulation of Adipose Tissue Inflammation by P-selectin Glycoprotein Ligand-1$0
I01 · FY2013 · VA · contact PI
Leptin in Vascular Disease$373,392
R01 · FY2012 · HL · contact PI
Regulation of Adipose Tissue Inflammation by P-selectin Glycoprotein Ligand-1$0
I01 · FY2012 · VA · contact PI
Leptin in Vascular Disease$377,429
R01 · FY2011 · HL · contact PI
Regulation of Adipose Tissue Inflammation by P-selectin Glycoprotein Ligand-1$0
I01 · FY2011 · VA · contact PI
Leptin in Vascular Disease$377,685
R01 · FY2010 · HL · contact PI
Leptin in Vascular Disease$377,935
R01 · FY2009 · HL · contact PI
Regulation of Adipose Tissue Inflammation by P-selectin Glycoprotein Ligand-1$0
I01 · FY2009 · VA · contact PI
Genetic Models for the Study of Fibrinolysis in the Vasculature$361,565
P01 · FY2007 · HL · contact PI
Leptin in Vascular Disease$322,147
R01 · FY2007 · HL · contact PI
Genetic Models for the Study of Fibrinolysis in the Vasculature$356,588
P01 · FY2006 · HL · contact PI
Leptin in Vascular Disease$353,717
R01 · FY2006 · HL · contact PI
Multidiscplinary Cardiovascular Research Training$223,564
T32 · FY2006 · HL · contact PI
Multidiscplinary Cardiovascular Research Training$391,625
T32 · FY2005 · HL
Leptin in Vascular Disease$362,820
R01 · FY2005 · HL
Genetic Models for the Study of Fibrinolysis in the Vasculature$350,183
P01 · FY2005 · HL
Multidisciplinary Cardiovascular Research Training$391,625
T32 · FY2004 · HL
Leptin in Vascular Disease$363,394
R01 · FY2004 · HL
Genetic Models for the Study of Fibrinolysis in the Vasculature$343,808
P01 · FY2004 · HL
Leptin in Vascular Disease$362,876
R01 · FY2003 · HL
PLASMINOGEN ACTIVATOR INHIBITOR-1 IN ATHEROSCLEROSIS$114,480
K08 · FY2001 · HL
PLASMINOGEN ACTIVATOR INHIBITOR-1 IN ATHEROSCLEROSIS$114,480
K08 · FY2000 · HL